1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Toke, O. Banoczi, Z. Kiraly, P. Heinzmann, R. Burck, J. Ulrich, A.S. Hudecz, F. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking GW Eur.Biophys.J. EBJOE8 0997 0175-7571 40 447 462 10.1007/s00249-010-0657-0 21234559 A kinked antimicrobial peptide from Bombina maxima. I. Three-dimensional structure determined by NMR in membrane-mimicking environments. 2011 2617.137 Antimicrobial peptide UNP residues 44-70 1 syn polymer no no GIGGVLLSAGKAALKGLAKVLAEKYAN GIGGVLLSAGKAALKGLAKVLAEKYAN A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n repository Initial release 1 0 2013-12-25 BMRB Y RCSB 2013-12-05 REL REL REL 161274 Giant fire-bellied toad, Chinese red belly toad Bombina maxima sample structures with the lowest energy 100 10 2D 1H-1H TOCSY 2D 1H-1H NOESY 2D 1H-15N HSQC 2D 1H-13C HSQC 1-1.2 mM 10 mM 200 mM [U-100% 2H] 220 5.0 ambient 313 K torsion angle dynamics, simulated annealing 1 lowest energy 1-1.2 mM maximin, 10 mM sodium-phosphate, 200 mM [U-100% 2H] d25-sodium-dodecyl-sulfate, 90% H2O/10% D2O 90% H2O/10% D2O Varian collection VNMRJ Accelrys peak picking Felix Accelrys processing Felix Linge, O'Donoghue and Nilges structure solution ARIA Linge, O'Donoghue and Nilges refinement ARIA Linge, O'Donoghue and Nilges geometry optimization ARIA 600 Varian Varian NMR System Varian Varian NMR System GLY 1 n 1 GLY 1 A ILE 2 n 2 ILE 2 A GLY 3 n 3 GLY 3 A GLY 4 n 4 GLY 4 A VAL 5 n 5 VAL 5 A LEU 6 n 6 LEU 6 A LEU 7 n 7 LEU 7 A SER 8 n 8 SER 8 A ALA 9 n 9 ALA 9 A GLY 10 n 10 GLY 10 A LYS 11 n 11 LYS 11 A ALA 12 n 12 ALA 12 A ALA 13 n 13 ALA 13 A LEU 14 n 14 LEU 14 A LYS 15 n 15 LYS 15 A GLY 16 n 16 GLY 16 A LEU 17 n 17 LEU 17 A ALA 18 n 18 ALA 18 A LYS 19 n 19 LYS 19 A VAL 20 n 20 VAL 20 A LEU 21 n 21 LEU 21 A ALA 22 n 22 ALA 22 A GLU 23 n 23 GLU 23 A LYS 24 n 24 LYS 24 A TYR 25 n 25 TYR 25 A ALA 26 n 26 ALA 26 A ASN 27 n 27 ASN 27 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A A HA HB1 ALA ALA 22 26 1.12 1 A A HG22 HD13 VAL LEU 5 6 1.28 2 A A HA HB1 ALA ALA 22 26 1.17 2 A A HG21 HD12 VAL LEU 5 6 1.30 3 A A HA HB3 ALA ALA 22 26 1.13 3 A A HG21 HD13 VAL LEU 5 6 1.29 4 A A HA HB1 ALA ALA 22 26 1.16 4 A A H H LEU LEU 6 7 1.33 5 A A HA HB3 ALA ALA 22 26 1.21 5 A A HG21 HD13 VAL LEU 5 6 1.31 6 A A HA HB3 ALA ALA 22 26 1.29 7 A A HA HB3 ALA ALA 22 26 1.17 7 A A HG22 HD11 VAL LEU 5 6 1.35 8 A A HA HB1 ALA ALA 22 26 1.21 8 A A HA HB2 ALA LEU 18 21 1.30 9 A A HA HB2 ALA ALA 22 26 1.13 9 A A HG21 HD12 VAL LEU 5 6 1.27 9 A A HA HB2 ALA LEU 18 21 1.33 10 A A HA HB2 ALA ALA 22 26 1.17 10 A A HG22 HD11 VAL LEU 5 6 1.28 1 -3.75 0.60 121.00 117.25 A A A CB CG CD1 TYR TYR TYR 25 25 25 N 2 -3.73 0.60 121.00 117.27 A A A CB CG CD1 TYR TYR TYR 25 25 25 N 3 -3.67 0.60 121.00 117.33 A A A CB CG CD1 TYR TYR TYR 25 25 25 N 5 -3.61 0.60 121.00 117.39 A A A CB CG CD1 TYR TYR TYR 25 25 25 N 6 -3.80 0.60 121.00 117.20 A A A CB CG CD1 TYR TYR TYR 25 25 25 N 7 -3.79 0.60 121.00 117.21 A A A CB CG CD1 TYR TYR TYR 25 25 25 N 8 -3.75 0.60 121.00 117.25 A A A CB CG CD1 TYR TYR TYR 25 25 25 N 9 -3.69 0.60 121.00 117.31 A A A CB CG CD1 TYR TYR TYR 25 25 25 N 10 -3.79 0.60 121.00 117.21 A A A CB CG CD1 TYR TYR TYR 25 25 25 N 1 A ILE 2 -118.83 -77.60 1 A LEU 6 176.25 -22.16 1 A LEU 7 -65.06 -77.04 1 A LYS 15 -92.77 -69.96 1 A LEU 17 -59.96 -8.11 2 A ILE 2 -104.86 -74.05 2 A LEU 6 178.13 -22.37 2 A LEU 7 -63.01 -78.38 2 A LYS 15 -86.10 -72.09 3 A ILE 2 -116.27 -81.53 3 A LEU 6 -179.87 -22.14 3 A LEU 7 -64.91 -79.07 3 A LYS 15 -94.74 -69.28 4 A ILE 2 -100.74 -79.61 4 A LEU 6 -166.50 -16.45 4 A LYS 15 -95.22 -69.60 5 A ILE 2 -103.11 -61.11 5 A VAL 5 -141.81 -59.49 5 A LEU 6 -171.82 -17.88 5 A LYS 15 -92.56 -70.27 6 A ILE 2 -116.38 -76.26 6 A LEU 6 -175.42 -23.34 6 A LEU 7 -62.44 -77.09 6 A LYS 15 -96.05 -70.89 7 A ILE 2 -130.87 -74.73 7 A LEU 6 -176.41 -22.91 7 A LEU 7 -65.18 -76.74 7 A LYS 15 -95.38 -72.25 8 A ILE 2 -103.72 -75.89 8 A LEU 6 -178.03 -23.02 8 A LEU 7 -63.92 -74.58 8 A LYS 15 -95.46 -70.61 8 A LEU 17 -58.40 -2.07 9 A ILE 2 -105.74 -79.13 9 A LEU 6 178.40 -20.85 9 A LYS 15 -95.08 -69.57 9 A LEU 17 -59.61 -2.68 10 A ILE 2 -95.07 -77.06 10 A LEU 6 173.84 -22.27 10 A LEU 7 -64.08 -74.70 10 A LYS 15 -92.81 -70.56 Antimicrobial peptide lowest energy, model1 The solution NMR structure of maximin-4 in SDS micelles 1 N N A LEU 7 A LEU 7 HELX_P A GLY 16 A GLY 16 1 1 10 A LEU 17 A LEU 17 HELX_P A TYR 25 A TYR 25 1 2 9 ANTIMICROBIAL PROTEIN, MEMBRANE PROTEIN membrane peptides, lipid bilayers, bacterial resistance, antimicrobial peptides, ANTIMICROBIAL PROTEIN, MEMBRANE PROTEIN C3RSY7_BOMMX UNP 1 44 C3RSY7 GIGGVLLSAGKAALKGLAKVLAEKYAN 44 70 2MHW 1 27 C3RSY7 A 1 1 27